Aymeric Duclert
15Patents
8h-index
20Co-inventors
72Inventor score
Filing activity: Aug 1, 1997 → Jul 2, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6783961B1 | Expressed sequence tags and encoded human proteins | Chemistry; Metallurgy | 89 | Expired |
| US6222029A | 5' ESTs for secreted proteins expressed in brain | Chemistry; Metallurgy | 54 | Expired |
| US6455280B1 | Methods and compositions for inhibiting neoplastic cell growth | Chemistry; Metallurgy | 42 | Expired |
| US6312922A | Complementary DNAs | Emerging Cross-Sectional Technologies | 28 | Expired |
| US6822072B1 | Expressed sequence tags and encoded human proteins | Chemistry; Metallurgy | 23 | Expired |
| US7393663B2 | Expressed sequence tags and encoded human proteins | Chemistry; Metallurgy | 10 | Expired |
| US6573068B1 | Claudin-50 protein | Chemistry; Metallurgy | 10 | Expired |
| US7115416B1 | Expressed sequence tags and encoded human proteins | Chemistry; Metallurgy | 9 | Expired |
| US7235381B2 | Expressed sequence tags and encoded human proteins | Chemistry; Metallurgy | 4 | Expired |
| US9290748B2 | Use of endonucleases for inserting transgenes into safe harbor loci | Chemistry; Metallurgy | 4 | Active |
| US7122644B2 | Methods and compositions for inhibiting neoplastic cell growth | Chemistry; Metallurgy | 2 | Expired |
| US6787647B1 | Carnitine carrier related protein-1 | Chemistry; Metallurgy | 2 | Expired |
| US6936692B2 | Complementary DNAs | Emerging Cross-Sectional Technologies | 1 | Expired |
| US12144825B2 | Cellular immunotherapy for repetitive administration | Chemistry; Metallurgy | 0 | Active |
| US7056680B2 | Antibodies to claudin-50 polypeptide | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.